Tradestie Institutional Equity Comparison Engine

KURA vs MESO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MESO Overall Edge

MESO Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Mesoblast Limited American Depositary Shares (MESO) driven by superior Growth & Margin, Momentum & Technical while KURA counters with relative strength in Options & Structure. Fundamentally, KURA trades at N/M Forward P/E with -394.3% operating margin (+10.1% YoY revenue) versus MESO at N/M Forward P/E and -42.6% operating margin (+390.7% YoY). In options structure, KURA sits in BREAKDOWN (20th %ile IV; Dealer Gamma Walls on Pro) against MESO sits in UNCLASSIFIED (37th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
KURA N/M vs MESO N/M Fwd P/E
Growth & Margin Winner MESO
Op Margin -394.3% vs -42.6% ยท YoY +10.1% vs +390.7%
Momentum & Technical Winner MESO
1Y -31.6% vs -16.4% ยท 52W Pos 8% vs 6%
Options & Structure Winner KURA
BREAKDOWN (20th %ile IV) vs UNCLASSIFIED (37th %ile IV)
KURA NASDAQ
Kura Oncology, Inc.
Pharmaceutical Preparations
$7.30
-6.05% 1D
Market Cap $690.9M
1M Return -19.6%
1Y Return -31.65%
Forward P/E N/M
Unified AI Score
64.1 / 100 BUY
Tech 63.0 Fund 64.0 Flow 67.0 Mom 60.0
MESO NASDAQ
Mesoblast Limited American Depositary Shares
Biological Products, (No Diagnostic Substances)
$12.47
-6.03% 1D
Market Cap $1.7B
1M Return -6.1%
1Y Return -16.42%
Forward P/E N/M
Unified AI Score
35.5 / 100 SELL
Tech 25.0 Fund 40.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: KURA -31.65% MESO -16.42% Spread: +15.23 pp (MESO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
KURA TTM Op. Margin: -394.3% MESO TTM Op. Margin: -42.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KURA vs MESO. Trailing 12-month operating profitability (KURA -394.3% vs MESO -42.6%) and valuation multiples (KURA N/M vs MESO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: KURA (3) vs MESO (5)
Institutional Metric KURA MESO Criterion Row Winner
Market Capitalization Scale $690.9M $1.7B Larger Scale MESO
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +10.1% +390.7% Higher Growth MESO
Operating Margin (TTM) Profitability -394.3% -42.6% Higher Margin MESO
Net Profit Margin Profitability 0.0% -47.8% Higher Margin KURA
Return on Equity (ROE) Capital Efficiency -224.8% -9.9% Higher ROE MESO
52-Week Range Position Momentum 8% ($7โ€“$14) 6% ($12โ€“$22) Stronger Trend KURA
Beta / 30D Volatility Risk Regime 1.42ฮฒ ยท 108% Vol 1.18ฮฒ ยท 78% Vol Lower Realized Risk MESO
Unified Institutional Score Composite Signal 64.1 / 100 (BUY) 35.5 / 100 (SELL) Higher Composite KURA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full KURA vs MESO Buy Guide
KURA BREAKDOWN
58d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 20th %ile
IV Regime Compressed (<25th %ile)
Live KURA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MESO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 37th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live MESO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither KURA nor MESO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.